BioStar Ventures
QuietFiled to raiseCharlevoix, MIHealthcare, Manufacturing, BiotechnologyLast fund filed December 2021
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| BioStar Ventures V | December 2021 | Indefinite | $79M | 175 |
| BioStar Ventures V-A | December 2021 | Indefinite | $10M | 66 |
| BioStar Ventures III-XFFiled to raise in 2018, with no closing reported yet. | 2018 | $20M | $0 | 0 |
| BioStar Ventures III | June 2013 | $100M | $68M | 69 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
5 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Louis Cannon | Quiet | Medical devices | 4 | 0 |
Classified sectors of BioStar Ventures’s own portfolio companies, based on 11 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of BioStar Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Domain Partners | 2 | Kona Medical, Trice Medical |
| Venture Investors Health | 2 | Delphinus Medical Technologies, Great Lakes Pharmaceuticals |
| Arboretum Ventures | 1 | Delphinus Medical Technologies |
| Baird Venture Partners |
| Michael FultonNot on the current fund | Quiet | Medical devices, Biotech & pharma | 4 | 0 |
| Paul ScottNot on the current fund | Quiet | None listed | 4 | 0 |
| Renee MasiNot on the current fund | Quiet | Medical devices | 4 | 0 |
| Steven Almany | Quiet | Medical devices | 2 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| 1 |
| NEOCHORD |
| Catalyst Health Ventures | 1 | Aria CV |
| Healthquest Partners | 1 | Trice Medical |
| Imaginary Venture Capital | 1 | SYNERGEYES |
| KSN | 1 | Pie Management Holdco |
| Lightstone Ventures | 1 | Kona Medical |
| Sofinnova Venture Partners | 1 | Trice Medical |
| Sonder Futures | 1 | SYNERGEYES |
| Treo Ventures | 1 | NEOCHORD |
| U.S Venture Partners | 1 | NEOCHORD |
A shared board seat: a company where filings name a BioStar Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.